Ventricular Assist Devices / Heart Transplantation
Minimally Invasive Cardiac Surgery / Robotic and Hybrid Surgery
Endovascular and Stent Graft Surgery
Peripheral Vascular Surgery
The Department of Cardiovascular Surgery at Osaka University has been a top-class contributor to the development of the Japanese cardiovascular surgical field since 1956, with the first successful open heart surgery using a heart-lung machine
in Japan. Since then, we have devoted ourselves not only to improving surgical results but also to the development and dissemination of new treatments for valvular disease, coronary artery disease, aortic disease, and congenital heart disease.
New treatments include minimally invasive cardiac surgery (MICS) and surgical treatment for heart failure.
We have enthusiastically adopted MICS for its ability to achieve bypass surgery without the need for a heart-lung machine, and so reducing surgical risks and injuries as much as possible. We have achieved many successes over the years, such as the pioneering 1993 application of stent graft therapy for aortic aneurysm, and the 2009 implementation of transcatheter aortic valve implantation (TAVI) for aortic valve stenosis patients with a high risk for open heart surgery. Regarding surgical treatment for heart failure, we have pioneered new methods to establish treatment protocols for heart transplantation, ventricular assist devices, regenerative medicine, and more.
Finally, we have established a care system that can provide comprehensive and state-of-the-art medical care, by assembling a heart team that combines the knowledge and experience of cardiovascular medicine, other medical departments, and paramedics.
In this way, the Department of Cardiovascular Surgery fulfills its mission of creating valuable new cardiovascular science. As well as minimally-invasive surgery, we are pioneering in areas such as organ transplant, ventricular assist devices, and regenerative treatment, so we can continue to deliver the latest and best medical care to our patients.